SAN FRANCISCO--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the release of 11 new AlphaScreen® SureFire® assay kits for the rapid detection of full-length kinase activation in cell lysates. The new kits launched at the 48th annual meeting of The American Society for Cell Biology (ASCB) represent new assays for mapping of cellular kinase pathways involved in many complex diseases such as cancer, cardiovascular, inflammation, and metabolism disorders.
